✦ LIBER ✦

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

✍ Scribed by Buse, John B; Nauck, Michael; Forst, Thomas; Sheu, Wayne H-H; Shenouda, Sylvia K; Heilmann, Cory R; Hoogwerf, Byron J; Gao, Aijun; Boardman, Marilyn K; Fineman, Mark; Porter, Lisa; Schernthaner, Guntram

Book ID: 120554790
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 389 KB
Volume: 381
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(12)61267-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-weekly dulaglutide versus once-dail

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial

✍ Dungan, Kathleen M; Povedano, Santiago Tofé; Forst, Thomas; González, José G Gon 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 535 KB

Exenatide once weekly versus twice daily

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

✍ Daniel J Drucker; John B Buse; Kristin Taylor; David M Kendall; Michael Trautman 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 276 KB

Once-weekly albiglutide versus once-dail

Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study

✍ Pratley, Richard E; Nauck, Michael A; Barnett, Anthony H; Feinglos, Mark N; Oval 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 288 KB

Exenatide once weekly versus insulin gla

Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial

✍ Diamant, Michaela; Van Gaal, Luc; Guerci, Bruno; Stranks, Stephen; Han, Jenny; M 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 442 KB

Once weekly exenatide compared with insu

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

✍ Michaela Diamant; Luc Van Gaal; Stephen Stranks; Justin Northrup; Dachuang Cao; 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 496 KB

Liraglutide once a day versus exenatide

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

✍ John B Buse; Julio Rosenstock; Giorgio Sesti; Wolfgang E Schmidt; Eduard Montany 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 244 KB